Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation

robot
Abstract generation in progress

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Treace Medical Concepts, Inc. (TMCI) and its officers/directors. The firm is encouraging investors who purchased Treace Medical securities prior to May 8, 2023, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC, a nationally recognized firm specializing in securities fraud class actions, operates on a contingency fee basis.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin